Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Gene Synthesis Software Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
  • 1.2.2 Solid Phase Synthesis
  • 1.2.3 Chip-based DNA Synthesis
  • 1.2.4 PCR-based Enzyme Synthesis
• 1.3 Market by Application
  • 1.3.1 Global Gene Synthesis Software Market Share by Application: 2017 VS 2021 VS 2028
  • 1.3.2 Academic and Research Institutes
  • 1.3.3 Biotech and Pharmaceutical
  • 1.3.4 Diagnostic Laboratories
  • 1.3.5 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Gene Synthesis Software Market Perspective (2017-2028)
• 2.2 Gene Synthesis Software Growth Trends by Region
  • 2.2.1 Gene Synthesis Software Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 Gene Synthesis Software Historic Market Size by Region (2017-2022)
  • 2.2.3 Gene Synthesis Software Forecasted Market Size by Region (2023-2028)
• 2.3 Gene Synthesis Software Market Dynamics
  • 2.3.1 Gene Synthesis Software Industry Trends
  • 2.3.2 Gene Synthesis Software Market Drivers
  • 2.3.3 Gene Synthesis Software Market Challenges
  • 2.3.4 Gene Synthesis Software Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Gene Synthesis Software Players by Revenue
  • 3.1.1 Global Top Gene Synthesis Software Players by Revenue (2017-2022)
  • 3.1.2 Global Gene Synthesis Software Revenue Market Share by Players (2017-2022)
• 3.2 Global Gene Synthesis Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Players Covered: Ranking by Gene Synthesis Software Revenue
• 3.4 Global Gene Synthesis Software Market Concentration Ratio
  • 3.4.1 Global Gene Synthesis Software Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Gene Synthesis Software Revenue in 2021
• 3.5 Gene Synthesis Software Key Players Head office and Area Served
• 3.6 Key Players Gene Synthesis Software Product Solution and Service
• 3.7 Date of Enter into Gene Synthesis Software Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Synthesis Software Breakdown Data by Type

• 4.1 Global Gene Synthesis Software Historic Market Size by Type (2017-2022)
• 4.2 Global Gene Synthesis Software Forecasted Market Size by Type (2023-2028)

5 Gene Synthesis Software Breakdown Data by Application

• 5.1 Global Gene Synthesis Software Historic Market Size by Application (2017-2022)
• 5.2 Global Gene Synthesis Software Forecasted Market Size by Application (2023-2028)

6 North America

• 6.1 North America Gene Synthesis Software Market Size (2017-2028)
• 6.2 North America Gene Synthesis Software Market Size by Country (2017-2022)
• 6.3 North America Gene Synthesis Software Market Size by Country (2023-2028)
• 6.4 United States
• 6.5 Canada

7 Europe

• 7.1 Europe Gene Synthesis Software Market Size (2017-2028)
• 7.2 Europe Gene Synthesis Software Market Size by Country (2017-2022)
• 7.3 Europe Gene Synthesis Software Market Size by Country (2023-2028)
• 7.4 Germany
• 7.5 France
• 7.6 U.K.
• 7.7 Italy
• 7.8 Russia
• 7.9 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific Gene Synthesis Software Market Size (2017-2028)
• 8.2 Asia-Pacific Gene Synthesis Software Market Size by Country (2017-2022)
• 8.3 Asia-Pacific Gene Synthesis Software Market Size by Country (2023-2028)
• 8.4 China
• 8.5 Japan
• 8.6 South Korea
• 8.7 Southeast Asia
• 8.8 India
• 8.9 Australia

9 Latin America

• 9.1 Latin America Gene Synthesis Software Market Size (2017-2028)
• 9.2 Latin America Gene Synthesis Software Market Size by Country (2017-2022)
• 9.3 Latin America Gene Synthesis Software Market Size by Country (2023-2028)
• 9.4 Mexico
• 9.5 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Gene Synthesis Software Market Size (2017-2028)
• 10.2 Middle East & Africa Gene Synthesis Software Market Size by Country (2017-2022)
• 10.3 Middle East & Africa Gene Synthesis Software Market Size by Country (2023-2028)
• 10.4 Turkey
• 10.5 Saudi Arabia
• 10.6 UAE

11 Key Players Profiles

• 11.1 Eurofins Genomics
  • 11.1.1 Eurofins Genomics Company Detail
  • 11.1.2 Eurofins Genomics Business Overview
  • 11.1.3 Eurofins Genomics Gene Synthesis Software Introduction
  • 11.1.4 Eurofins Genomics Revenue in Gene Synthesis Software Business (2017-2022)
  • 11.1.5 Eurofins Genomics Recent Development
• 11.2 ATUM
  • 11.2.1 ATUM Company Detail
  • 11.2.2 ATUM Business Overview
  • 11.2.3 ATUM Gene Synthesis Software Introduction
  • 11.2.4 ATUM Revenue in Gene Synthesis Software Business (2017-2022)
  • 11.2.5 ATUM Recent Development
• 11.3 Biotage
  • 11.3.1 Biotage Company Detail
  • 11.3.2 Biotage Business Overview
  • 11.3.3 Biotage Gene Synthesis Software Introduction
  • 11.3.4 Biotage Revenue in Gene Synthesis Software Business (2017-2022)
  • 11.3.5 Biotage Recent Development
• 11.4 Bioneer Corporation
  • 11.4.1 Bioneer Corporation Company Detail
  • 11.4.2 Bioneer Corporation Business Overview
  • 11.4.3 Bioneer Corporation Gene Synthesis Software Introduction
  • 11.4.4 Bioneer Corporation Revenue in Gene Synthesis Software Business (2017-2022)
  • 11.4.5 Bioneer Corporation Recent Development
• 11.5 Eurogentec
  • 11.5.1 Eurogentec Company Detail
  • 11.5.2 Eurogentec Business Overview
  • 11.5.3 Eurogentec Gene Synthesis Software Introduction
  • 11.5.4 Eurogentec Revenue in Gene Synthesis Software Business (2017-2022)
  • 11.5.5 Eurogentec Recent Development
• 11.6 GenScript
  • 11.6.1 GenScript Company Detail
  • 11.6.2 GenScript Business Overview
  • 11.6.3 GenScript Gene Synthesis Software Introduction
  • 11.6.4 GenScript Revenue in Gene Synthesis Software Business (2017-2022)
  • 11.6.5 GenScript Recent Development
• 11.7 GENEWIZ
  • 11.7.1 GENEWIZ Company Detail
  • 11.7.2 GENEWIZ Business Overview
  • 11.7.3 GENEWIZ Gene Synthesis Software Introduction
  • 11.7.4 GENEWIZ Revenue in Gene Synthesis Software Business (2017-2022)
  • 11.7.5 GENEWIZ Recent Development
• 11.8 Integrated DNA Technologies
  • 11.8.1 Integrated DNA Technologies Company Detail
  • 11.8.2 Integrated DNA Technologies Business Overview
  • 11.8.3 Integrated DNA Technologies Gene Synthesis Software Introduction
  • 11.8.4 Integrated DNA Technologies Revenue in Gene Synthesis Software Business (2017-2022)
  • 11.8.5 Integrated DNA Technologies Recent Development
• 11.9 OriGene Technologies
  • 11.9.1 OriGene Technologies Company Detail
  • 11.9.2 OriGene Technologies Business Overview
  • 11.9.3 OriGene Technologies Gene Synthesis Software Introduction
  • 11.9.4 OriGene Technologies Revenue in Gene Synthesis Software Business (2017-2022)
  • 11.9.5 OriGene Technologies Recent Development
• 11.10 Thermo Fisher Scientific
  • 11.10.1 Thermo Fisher Scientific Company Detail
  • 11.10.2 Thermo Fisher Scientific Business Overview
  • 11.10.3 Thermo Fisher Scientific Gene Synthesis Software Introduction
  • 11.10.4 Thermo Fisher Scientific Revenue in Gene Synthesis Software Business (2017-2022)
  • 11.10.5 Thermo Fisher Scientific Recent Development
• 11.11 Bio Basic
  • 11.11.1 Bio Basic Company Detail
  • 11.11.2 Bio Basic Business Overview
  • 11.11.3 Bio Basic Gene Synthesis Software Introduction
  • 11.11.4 Bio Basic Revenue in Gene Synthesis Software Business (2017-2022)
  • 11.11.5 Bio Basic Recent Development
• 11.12 Twist Bioscience
  • 11.12.1 Twist Bioscience Company Detail
  • 11.12.2 Twist Bioscience Business Overview
  • 11.12.3 Twist Bioscience Gene Synthesis Software Introduction
  • 11.12.4 Twist Bioscience Revenue in Gene Synthesis Software Business (2017-2022)
  • 11.12.5 Twist Bioscience Recent Development
• 11.13 BioCat GmbH
  • 11.13.1 BioCat GmbH Company Detail
  • 11.13.2 BioCat GmbH Business Overview
  • 11.13.3 BioCat GmbH Gene Synthesis Software Introduction
  • 11.13.4 BioCat GmbH Revenue in Gene Synthesis Software Business (2017-2022)
  • 11.13.5 BioCat GmbH Recent Development
• 11.14 ProteoGenix
  • 11.14.1 ProteoGenix Company Detail
  • 11.14.2 ProteoGenix Business Overview
  • 11.14.3 ProteoGenix Gene Synthesis Software Introduction
  • 11.14.4 ProteoGenix Revenue in Gene Synthesis Software Business (2017-2022)
  • 11.14.5 ProteoGenix Recent Development
• 11.15 Charles River
  • 11.15.1 Charles River Company Detail
  • 11.15.2 Charles River Business Overview
  • 11.15.3 Charles River Gene Synthesis Software Introduction
  • 11.15.4 Charles River Revenue in Gene Synthesis Software Business (2017-2022)
  • 11.15.5 Charles River Recent Development
• 11.16 Biosearch Technologies
  • 11.16.1 Biosearch Technologies Company Detail
  • 11.16.2 Biosearch Technologies Business Overview
  • 11.16.3 Biosearch Technologies Gene Synthesis Software Introduction
  • 11.16.4 Biosearch Technologies Revenue in Gene Synthesis Software Business (2017-2022)
  • 11.16.5 Biosearch Technologies Recent Development
• 11.17 Beijing SBS Genetech
  • 11.17.1 Beijing SBS Genetech Company Detail
  • 11.17.2 Beijing SBS Genetech Business Overview
  • 11.17.3 Beijing SBS Genetech Gene Synthesis Software Introduction
  • 11.17.4 Beijing SBS Genetech Revenue in Gene Synthesis Software Business (2017-2022)
  • 11.17.5 Beijing SBS Genetech Recent Development
• 11.18 Eton Bioscience
  • 11.18.1 Eton Bioscience Company Detail
  • 11.18.2 Eton Bioscience Business Overview
  • 11.18.3 Eton Bioscience Gene Synthesis Software Introduction
  • 11.18.4 Eton Bioscience Revenue in Gene Synthesis Software Business (2017-2022)
  • 11.18.5 Eton Bioscience Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Summary:

Gene synthesis is a technology of artificially synthesizing genes, and it is one of the means of gene acquisition. Compared with the acquisition of genes from existing organisms, gene synthesis does not require templates, so it is not limited by the source of genes. Gene synthesis software enables rapid and efficient gene construction and synthesis in a single reaction.
Industry Insights
The global Gene Synthesis Software market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Solid Phase Synthesis accounting for % of the Gene Synthesis Software global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Academic and Research Institutes segment is altered to an % CAGR throughout this forecast period.
China Gene Synthesis Software market size is valued at US$ million in 2021, while the North America and Europe Gene Synthesis Software are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Gene Synthesis Software landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gene Synthesis Software market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gene Synthesis Software market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gene Synthesis Software market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gene Synthesis Software market.
Impact of Covid-19 Outbreak
This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.
Segmental Analysis
The report has been segmented into product and application segments. The researchers have documented all the products present today in the Gene Synthesis Software market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.
Gene Synthesis Software Breakdown Data by Type
Solid Phase Synthesis
Chip-based DNA Synthesis
PCR-based Enzyme Synthesis
Gene Synthesis Software Breakdown Data by Application
Academic and Research Institutes
Biotech and Pharmaceutical
Diagnostic Laboratories
Others
Regional Analysis
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape
This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:
Eurofins Genomics
ATUM
Biotage
Bioneer Corporation
Eurogentec
GenScript
GENEWIZ
Integrated DNA Technologies
OriGene Technologies
Thermo Fisher Scientific
Bio Basic
Twist Bioscience
BioCat GmbH
ProteoGenix
Charles River
Biosearch Technologies
Beijing SBS Genetech
Eton Bioscience
Frequently Asked Questions
What factors will challenge the Gene Synthesis Software market growth?
Which end-use segment will expand at the fastest CAGR in the Gene Synthesis Software market?
Which are the emerging players in the Gene Synthesis Software market?
How concentrated is the Gene Synthesis Software market?
Which factors are positively contributing to the Gene Synthesis Software market growth?
Which are the novel product innovations in the Gene Synthesis Software market?
Which product segment will emerge as the most lucrative in the Gene Synthesis Software market?
Which factors are increasing the competition in the Gene Synthesis Software market?
Which are the strategic measures taken by the Gene Synthesis Software industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Gene Synthesis Software market in the coming years?